Jiangxi Synergy Pharmaceutical Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 1,623

Employees

  • Stock Symbol
  • 300636

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.97
  • (As of Friday Closing)

Jiangxi Synergy Pharmaceutical General Information

Description

Jiangxi Synergy Pharmaceutical Co Ltd is a China-based company that engages in the production of bulk drugs and intermediates. Its main products include anti-epileptic medicines, anti-ulcer medicines, anti-pyretic analgesics, non-steroid anti-inflammatory analgesics, anti-high blood pressure medicines, and anti-depression drugs.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Fengxin Industrial Park
  • Yichun, Jiangxi 330700
  • China
+86 0795
Primary Industry
Pharmaceuticals
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • Fengxin Industrial Park
  • Yichun, Jiangxi 330700
  • China
+86 0795

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jiangxi Synergy Pharmaceutical Stock Performance

As of 13-Nov-2026, Jiangxi Synergy Pharmaceutical’s stock price is $0.97. Its current market cap is $409M with 420M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.97 $0.98 $0.90 - $1.29 $409M 420M 4.86M

Jiangxi Synergy Pharmaceutical Financials Summary

As of 30-Sep-2026, Jiangxi Synergy Pharmaceutical has a trailing 12-month revenue of $116M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 475,556 499,402 544,455 665,513
Revenue 116,157 115,230 105,762 102,071
EBITDA 1,443 26,938 30,295 24,704
Net Income 4,045 10,164 14,854 14,980
Total Assets 436,757 474,657 454,727 454,454
Total Debt 27,005 90,972 96,266 108,478
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Jiangxi Synergy Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Jiangxi Synergy Pharmaceutical‘s full profile, request access.

Request a free trial

Jiangxi Synergy Pharmaceutical Patents

Jiangxi Synergy Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260347327-A1 Method for preparing key intermediate iii for resmetirom Pending 21-Sep-2023
WO-2025060509-A1 Method for preparing key intermediate iii of resmetirom Inactive 21-Sep-2023
US-11214581-B2 Method for preparing crisaborole Active 02-Jul-2019
US-20210053995-A1 Method for preparing crisaborole Active 02-Jul-2019
EP-2921473-A1 1-cyan-1-(7-methoxyl-1-naphtyl) methanol ester compound and preparation method and use thereof Active 09-Oct-2012 C07C213/02
To view Jiangxi Synergy Pharmaceutical’s complete patent history, request access »

Jiangxi Synergy Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jiangxi Synergy Pharmaceutical Investments (1)

Jiangxi Synergy Pharmaceutical’s most recent deal was a Corporate with Hangzhou Boya Biopharmaceutical for . The deal was made on 24-Apr-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hangzhou Boya Biopharmaceutical 24-Apr-2025 Corporate Pharmaceuticals
To view Jiangxi Synergy Pharmaceutical’s complete investments history, request access »

Jiangxi Synergy Pharmaceutical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Jiangxi Synergy Pharmaceutical’s complete esg history, request access »

Jiangxi Synergy Pharmaceutical FAQs

  • When was Jiangxi Synergy Pharmaceutical founded?

    Jiangxi Synergy Pharmaceutical was founded in 2004.

  • Where is Jiangxi Synergy Pharmaceutical headquartered?

    Jiangxi Synergy Pharmaceutical is headquartered in Yichun, China.

  • What is the size of Jiangxi Synergy Pharmaceutical?

    Jiangxi Synergy Pharmaceutical has 1,623 total employees.

  • What industry is Jiangxi Synergy Pharmaceutical in?

    Jiangxi Synergy Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is Jiangxi Synergy Pharmaceutical a private or public company?

    Jiangxi Synergy Pharmaceutical is a Public company.

  • What is Jiangxi Synergy Pharmaceutical’s stock symbol?

    The ticker symbol for Jiangxi Synergy Pharmaceutical is 300636.

  • What is the current stock price of Jiangxi Synergy Pharmaceutical?

    As of 13-Nov-2026 the stock price of Jiangxi Synergy Pharmaceutical is $0.97.

  • What is the current market cap of Jiangxi Synergy Pharmaceutical?

    The current market capitalization of Jiangxi Synergy Pharmaceutical is $409M.

  • What is Jiangxi Synergy Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Jiangxi Synergy Pharmaceutical is $116M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process